Re-imagining CRISPR Technology for Use with Primary Immune Cells: New Insights for Cell-Based Immunotherapy Research

In this webinar, Dr. Shifrut presents a novel pooled CRISPR screening technology with the potential to prioritize novel targets for cancer immunotherapy drug development and to improve the design of genetically reprogrammed cell-based therapies.
Publish Date: August 28, 2019 Views: 38